Download PDF
Thromb Haemost 2011; 106(02): 379-381
DOI: 10.1160/TH11-02-0066
Letters to the Editor
Schattauer GmbH

Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow)

Magdalena Celinska-Lowenhoff
1   II Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland
,
Teresa Iwaniec
1   II Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland
,
Martine Alhenc-Gelas
3   Hématologie biologique, AP-HP Hôpital Européen G. Pompidou, Paris, France
,
Jacek Musial
1   II Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland
,
Anetta Undas
1   II Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland
2   Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
› Author Affiliations Financial support: This study has been supported by a grant of Jagiellonian University (no. K/ZDS/000565 to A.U.) and by the DHOS (Direction de l’Hospitalisation et de l’Organisation des Soins) program ″Soutien financier en faveur des laboratoires pratiquant le diagnostic par génétique moléculaire des maladies rares″ (to M.A.-G.).
Further Information

Publication History

Received: 02 February 2011

Accepted after major revision: 15 May 2011

Publication Date:
25 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia 2008; 14: 1229-1239.
    CrossrefPubMedGoogle Scholar
  • 2 Sharpe CJ, Crowther MA, Webert KE. et al. Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review. Transfus Med Rev 2011; 25: 61-65.
    CrossrefPubMedGoogle Scholar
  • 3 Lane DA, Bayston T, Olds RJ. et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Picard V, Chen JM, Tardy B. et al. Detection and characterization of large SERPINC1 deletions in type I inherited antithrombin deficiency. Hum Genet 2010; 127: 45-53.
    CrossrefPubMedGoogle Scholar
  • 5 Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemost 1987; 18: 1094.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Picard V, Nowak-Göttl U, Biron-Andreani C. et al. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat 2006; 27: 600.
    PubMedGoogle Scholar
  • 7 Undas A, Zawilska K, Ciesla-Dul M. et al. Altered fibrin clot structure/function in patients with idio pathic venous thromboembolism and in their relatives. Blood 2009; 114: 4272-4278.
    CrossrefPubMedGoogle Scholar
  • 8 Lisman T, de Groot PG, Meijers JCM. et al. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005; 15: 1102-1105.
    PubMedGoogle Scholar
  • 9 Wolf M, Boyer C, Tripodi A. et al. Antithrombin Milano: A new variant with monomeric and dimeric inactive antithrombin III. Blood 1985; 65: 496-500.
    PubMedGoogle Scholar
  • 10 Scott EM, Ariëns RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
    CrossrefPubMedGoogle Scholar
  • 11 Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142.
    CrossrefPubMedGoogle Scholar
  • 12 Campbell RA, Overmyer KA, Bagnell R. et al. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol 2008; 28: 2247-2254.
    CrossrefPubMedGoogle Scholar
  • 13 Fatah K, Silveira A, Tornvall P. et al. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996; 76: 535-540.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Jochmans K, Lissens W, Vervoort R. et al. Anti-thrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994; 83: 146-151.
    PubMedGoogle Scholar
  • 15 Kuhle S, Lane DA, Johamanns A. et al. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost 2001; 86: 1007-1011.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Roldán V, Ordoñez A, Marín F. et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost 2009; 101: 483-486.
    Article in Thieme ConnectPubMedGoogle Scholar